BATON ROUGE, La., Jan. 26, 2016 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB) announced today Senior Vice President and Chief Financial Officer Scott A. Tozier will be on a temporary medical leave of absence, effective immediately. It is anticipated that he will return to his normal duties in the near future. In Mr. Tozier's absence, other executive officers of the company will assume Mr. Tozier's management duties while remaining in their current positions. In particular, Senior Vice President of Corporate Strategy and Investor Relations Matthew K. Juneau will assume management responsibility of Albemarle's finance and accounting, tax and treasury teams.
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a premier specialty chemicals company with leading positions in attractive end markets around the world. With a broad customer reach and diverse end markets, Albemarle develops, manufactures and markets technologically advanced and high value added products, including lithium and lithium compounds, bromine and bromine derivatives, catalysts and surface treatment chemistries used in a wide range of applications including consumer electronics, flame retardants, metal processing, plastics, contemporary and alternative transportation vehicles, refining, pharmaceuticals, agriculture, construction and custom chemistry services. Albemarle is focused on delivering differentiated, performance-based technologies that deliver innovative and sustainable solutions to its customers. The Company employs approximately 6,900 people and serves customers in approximately 100 countries. Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings and other information regarding the Company, its businesses and the markets it serves.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.
Logo - https://photos.prnewswire.com/prnh/20111129/MM14279LOGO
To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/albemarle-cfo-to-take-temporary-medical-leave-of-absence-300209496.html
SOURCE Albemarle Corporation
Albemarle Media Contact: Ashley Mendoza, (225) 388-7137, Ashley.Mendoza@albemarle.com or Albemarle Investor Relations Contact: Matt Juneau, (225) 388-7940, Matt.Juneau@albemarle.com